(Q50343808)

5 March 2018

title

A double-blind, placebo-controlled trial of oral human immunoglobulin for gastrointestinal dysfunction in children with autistic disorder. (English)

1 reference

5 March 2018

0 references

1 reference

placebo-controlled trial

1 reference

inferred from title

author

Christopher J McDougle

7

object named as

Christopher J McDougle

1 reference

5 March 2018

4

Michael G Aman

1 reference

5 March 2018

author name string

Benjamin L Handen

1

1 reference

5 March 2018

Raun D Melmed

2

1 reference

5 March 2018

Robin L Hansen

3

1 reference

5 March 2018

David L Burnham

5

1 reference

5 March 2018

Jon B Bruss

6

1 reference

5 March 2018

language of work or name

English

0 references

publication date

16 January 2009

1 reference

5 March 2018

Journal of Autism and Developmental Disorders

published in

1 reference

5 March 2018

volume

39

1 reference

5 March 2018

issue

5

1 reference

5 March 2018

page(s)

796-805

1 reference

5 March 2018

Infantile autism: a genetic study of 21 twin pairs

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10803-008-0687-Y

Use of Complementary and Alternative Treatments for Children with Autistic Spectrum Disorders Is Increasing

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10803-008-0687-Y

Prevalence of chronic gastrointestinal symptoms in children with autism and autistic spectrum disorders

21 January 2018

1 reference

12 December 2020

Protection by milk immunoglobulin concentrate against oral challenge with enterotoxigenic Escherichia coli.

1 reference

12 December 2020

Brief report: autistic disorder in three children with cytomegalovirus infection.

1 reference

12 December 2020

Positive effects of methylphenidate on inattention and hyperactivity in pervasive developmental disorders: an analysis of secondary measures.

1 reference

12 December 2020

Intestinal lymphocyte populations in children with regressive autism: evidence for extensive mucosal immunopathology

1 reference

12 December 2020

Elimination diets in autism spectrum disorders: any wheat amidst the chaff?

1 reference

12 December 2020

Frequency of gastrointestinal symptoms in children with autistic spectrum disorders and association with family history of autoimmune disease.

1 reference

12 December 2020

Efficacy of bovine milk immunoglobulin concentrate in preventing illness after Shigella flexneri challenge

1 reference

12 December 2020

Autism and gastrointestinal symptoms

1 reference

12 December 2020

A randomised trial of oral gammaglobulin in low-birth-weight infants infected with rotavirus

1 reference

12 December 2020

Measles, mumps, and rubella vaccination and bowel problems or developmental regression in children with autism: population study

1 reference

12 December 2020

Oral immunoglobulin treatment in Crohn's disease

1 reference

12 December 2020

Autism and the immune system

1 reference

12 December 2020

Oral immunoglobulins for treatment of acute rotaviral gastroenteritis

1 reference

12 December 2020

Oral human immunoglobulin for children with autism and gastrointestinal dysfunction: a prospective, open-label study.

1 reference

12 December 2020

Treatment planning for patients with autism spectrum disorders

1 reference

12 December 2020

Autism Diagnostic Interview-Revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders

1 reference

12 December 2020

How common are gastrointestinal disorders in children with autism?

1 reference

12 December 2020

Assessment in multisite randomized clinical trials of patients with autistic disorder: the Autism RUPP Network. Research Units on Pediatric Psychopharmacology

1 reference

12 December 2020

Short-term benefit from oral vancomycin treatment of regressive-onset autism

1 reference

12 December 2020

Famotidine treatment of children with autistic spectrum disorders: pilot research using single subject research design

1 reference

12 December 2020

Treatment of chronic cryptosporidial infection with orally administered human serum immune globulin

1 reference

12 December 2020

The aberrant behavior checklist: a behavior rating scale for the assessment of treatment effects.

1 reference

12 December 2020

Psychometric characteristics of the aberrant behavior checklist

1 reference

12 December 2020

Gastrointestinal Factors in Autistic Disorder: A Critical Review

1 reference

12 December 2020

Validation of irritable bowel syndrome Global Improvement Scale: an integrated symptom end point for assessing treatment efficacy

1 reference

12 December 2020

Lack of effect of orally administered human serum immunoglobulin on the normal human oral and intestinal microflora

1 reference

12 December 2020

Risperidone in children with autism and serious behavioral problems

1 reference

12 December 2020

Oral immunoglobulin A supplement in treatment of Clostridium difficile enteritis

1 reference

12 December 2020

Colonic CD8 and gamma delta T-cell infiltration with epithelial damage in children with autism.

1 reference

12 December 2020

Gastrointestinal abnormalities in children with autistic disorder

1 reference

12 December 2020

Small intestinal enteropathy with epithelial IgG and complement deposition in children with regressive autism

1 reference

12 December 2020

Serological association of measles virus and human herpesvirus-6 with brain autoantibodies in autism

1 reference

12 December 2020

Oral administration of human serum immunoglobulin in immunodeficient patients with viral gastroenteritis. A pharmacokinetic and functional analysis

1 reference

12 December 2020

10.1007/S10803-008-0687-Y

Identifiers

DOI

1 reference

5 March 2018

1 reference

5 March 2018